Wacker Chemie’s Q2 Profit Jump Is Flattered by One-Offs — Guidance Tells the Real Story

Wacker Chemie’s Mixed Half-Year: Higher Profit, Reduced Revenue Ambition

Wacker Chemie has reported a sharp jump in second-quarter net profit to €350 million, swinging from a loss of €19 million a year earlier. Investors took the numbers coolly, and the company itself has sent a mixed signal for the full year: it raised its EBITDA guidance but trimmed its revenue growth forecast.

The headline profit is heavily influenced by one-off effects. Around €243 million relates to Siltronic-related items, after the company placed 2.1 million shares in its wafer subsidiary in May, and a further €37 million comes from cutting pension provisions. That leaves the underlying quarterly profit well below the reported figure, although management says its cost and efficiency programme also contributed to a better operating performance.

Revenue rose 7% year on year to €1.52 billion, while EBITDA climbed 85% to €211 million. For 2026, Wacker now expects revenue growth in the mid-single-digit percentage range, down from a previous forecast of high single-digit growth. At the same time, it lifted its EBITDA target to €625-750 million from €550-700 million.

The combination of lower revenue growth and higher profitability points to a business that is earning more per unit sold rather than selling much more. Wacker says the efficiency programme is on track to deliver €300 million of annual savings in 2026, though it has not said how much of that fell into the second quarter. The stock rose after the report but remains in a short-term downward trend on the charts.

The Real Signal Inside Wacker’s Q2 Numbers

A Profit Number That Needs an Asterisk

The reported net profit of €350 million looks like a decisive turnaround, but it is not a clean measure of operating progress. The Siltronic-related effects of about €243 million and the €37 million pension provision reduction together amount to roughly €280 million. Even before considering taxes and other normalisation, the bulk of the quarter's reported profit stems from non-operating items. Investors' muted reaction to the release is consistent with that reading.

Revenue Down, Margin Up: The Gulf Factor

The guidance change is the most informative part of the statement. Wacker now expects only mid-single-digit revenue growth for 2026, suggesting weaker demand at home is being factored in, particularly for a cyclical chemicals business. The EBITDA outlook, however, has been raised by a wide margin. Management attributes part of the improvement to its cost programme, but the price-versus-volume dynamic appears to be the main driver: developments in the Gulf region are reportedly helping pricing more than volumes. That would explain why profitability improves while revenue ambitions are trimmed.

Near Book Value, But So Are Peers

With a market capitalisation of around €4.3 billion, Wacker's shares trade close to book value. The analysis notes this is not unusual in today's chemicals sector — Lanxess, for example, trades at barely more than half its book value. Low valuation may therefore signal sector-wide cyclical weakness rather than an attractive entry point for Wacker specifically. Technically, the stock is still in a short-term downtrend, and the industry outlook remains subdued.

What to Watch in Wacker’s Second Half

For investors following Wacker Chemie, the second-half reporting season will matter more than the headline second-quarter figure.

• Treat the €350 million net profit as non-comparable: roughly €243 million is tied to Siltronic-related effects from the May placement of 2.1 million shares, and €37 million to pension provision changes.
• Check whether the raised EBITDA range of €625-750 million is supported by real operating gains in Q3 and Q4; the company did not break out the cost programme's quarterly contribution.
• Watch the revenue trajectory. Management cut 2026 growth guidance to mid-single-digit percentages — any further downgrade would signal that weak domestic demand is hurting volumes more than pricing.
• Compare Wacker's near-book valuation with peers such as Lanxess, which trades at around half book value, before treating the multiple as a buy signal on its own.
• Keep Siltronic-related effects in the model: the May placement of 2.1 million shares added roughly €243 million to first-half profit, and any further stake changes would have a similar one-off impact.